Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Vestn Oftalmol ; 133(2): 22-28, 2017.
Artigo em Russo | MEDLINE | ID: mdl-28524136

RESUMO

AIM: to investigate neuromidin effectiveness in the treatment of patients with primary glaucoma and compensated intraocular pressure (IOP). MATERIAL AND METHODS: A total of 40 patients (80 eyes) were examined. Of them, 10 eyes with early glaucoma, 36 eyes with moderate-stage glaucoma, 33 eyes with advanced glaucoma, and 1 eye with end-stage glaucoma. In 19 eyes, IOP was controlled through beta-blockers, in 11 eyes - through carbonic anhydrase inhibitors, in 10 eyes - through prostaglandin analogues, and in 39 eyes - through combination drugs. Twenty-six eyes had received glaucoma surgery some time earlier. Ipidacrine was prescribed in tablets at 20 mg 2 times daily for 25 days. Treatment effectiveness was judged by visual functions, hydrodynamics, and morphometric parameters of the optic disc. RESULTS: In moderate-stage eyes, visual acuity improved in 66.6% of cases and remained unchanged in 33.3%. In advanced-stage eyes, visual acuity improved in 51.5% of cases and remained unchanged in 48.5%. Visual field broadened in all cases. Moreover, under the neuromidin therapy, the number of scotomas in early-stage eyes decreased, while the number of areas with normal sensitivity of the retina increased by 14.9%. In advanced-stage glaucoma, the effect was less pronounced: the number of type 1 and type 2 scotomas decreased by 3.0±0.6% and 2.9±0.8%, respectively; the number of absolute scotomas did not change; the number of areas with normal sensitivity of the retina increased by 7.4±2.0%. Also, P0 was found to be reduced and intraocular fluid outflow - activated. In early and moderate glaucoma, there was a significant reduction in the cup area as well as an increase in the neuroretinal rim area and retinal nerve fiber layer thickness. In advanced-stage cases, it was only the retinal nerve fiber layer thickness that changed. CONCLUSION: Neuromidin has a positive impact on visual function, hydrodynamics, and morphometric parameters of the optic disc.


Assuntos
Aminoquinolinas/administração & dosagem , Glaucoma , Adulto , Idoso , Anti-Hipertensivos/administração & dosagem , Anti-Hipertensivos/classificação , Inibidores da Colinesterase/administração & dosagem , Feminino , Glaucoma/diagnóstico , Glaucoma/tratamento farmacológico , Glaucoma/fisiopatologia , Humanos , Pressão Intraocular/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Fármacos Neuroprotetores/administração & dosagem , Hipertensão Ocular/diagnóstico , Hipertensão Ocular/tratamento farmacológico , Hipertensão Ocular/fisiopatologia , Disco Óptico/efeitos dos fármacos , Disco Óptico/fisiopatologia , Tonometria Ocular/métodos , Resultado do Tratamento , Acuidade Visual/efeitos dos fármacos , Testes de Campo Visual/métodos
2.
Vestn Oftalmol ; 118(1): 44-6, 2002.
Artigo em Russo | MEDLINE | ID: mdl-11898362

RESUMO

Visual functions, hydrodynamics, and bloodflow in internal carotid arteries were evaluated in 60 patients with primary glaucoma and essential hypertension. Effects of systemic and local beta-adrenoblockers and combinations of local hypotensive agents with calcium antagonists and angiotensin-converting enzyme inhibitors were studied. Negative effect of a combination of local and oral beta-adrenoblockers and positive effect of a combination of local hypotensive agents with oral capotene were revealed. Capotene is recommended for the treatment of glaucomatous patients with essential hypertension.


Assuntos
Anti-Hipertensivos/uso terapêutico , Glaucoma/tratamento farmacológico , Hipertensão/tratamento farmacológico , Administração Oral , Administração Tópica , Antagonistas Adrenérgicos beta/administração & dosagem , Antagonistas Adrenérgicos beta/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/administração & dosagem , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Anti-Hipertensivos/administração & dosagem , Bloqueadores dos Canais de Cálcio/administração & dosagem , Bloqueadores dos Canais de Cálcio/uso terapêutico , Glaucoma/complicações , Humanos , Hipertensão/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA